Related Experiment Video
Updated: Jul 14, 2026

Global Level Quantification of Histone Post-Translational Modifications in a 3D Cell Culture Model of Hepatic Tissue
Published on: May 5, 2022
Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of
Alvaro Rada-Iglesias1, Stefan Enroth, Adam Ameur
1Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, SE-751 05 Sweden. alvaro.rada@genpat.uu.se
Butyrate, a histone deacetylase inhibitor (HDACi), paradoxically deacetylates gene promoters, leading to gene repression. This challenges the current understanding of HDACi anti-cancer mechanisms and histone acetylation roles.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Pharmacology
Background:
- Histone deacetylase inhibitors (HDACi) like butyrate are explored for anti-cancer effects by theoretically reactivating silenced genes via histone acetylation.
- However, observed gene repression during HDACi treatment necessitates a deeper understanding of their molecular mechanisms.
Purpose of the Study:
- To investigate the precise effects of butyrate on histone acetylation patterns at gene promoters.
- To elucidate the relationship between butyrate-induced histone modifications and gene expression changes in cancer cells.
Main Methods:
- ChIP-chip assays were performed on HepG2 cells treated with butyrate to analyze histone H3 and H4 acetylation.
- Validation studies involved butyrate and trichostatin A treatment in HepG2 and HT-29 cells, assessing histone acetylation, nucleosome occupancy, and H3K4me3.
- RNA polymerase II (POLR2A) activity was examined to understand transcriptional regulation.
Main Results:
- Butyrate induced localized histone deacetylation at gene promoter regions, contrasting with global histone acetylation increases.
- This deacetylation occurred without significant changes in nucleosome loss or H3K4me3.
- Genes with deacetylated promoters were transcriptionally downregulated by butyrate, mediated by effects on POLR2A initiation/elongation.
- Global histone acetylation increases were localized to the nuclear periphery, suggesting a non-euchromatic association.
Conclusions:
- Butyrate's anti-neoplastic action may involve promoter-specific histone deacetylation and subsequent gene repression, challenging existing models.
- The findings suggest that HDACi's therapeutic effects might be more complex than previously thought, requiring revised mechanistic models.
- Localized histone deacetylation at promoters provides a molecular explanation for gene repression observed during HDACi therapy.
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at 9th...
Dysbiosis of the Gut Microbiota
Co-activators and Co-repressors

